High frequency of infection of lung cancer patients with the parasite Toxoplasma gondii.
Jaroslav BajnokMuyassar TarabulsiHelen CarlinKevin BownThomas SouthworthJosiah DungwaDave SinghZhao-Rong LunLucy SmythGeoff HidePublished in: ERJ open research (2019)
Clinicians treating lung cancer patients should be aware of the potential presence of the parasite, the potential for induction of symptomatic complications and interference with treatment success.
Keyphrases
- toxoplasma gondii
- high frequency
- end stage renal disease
- transcranial magnetic stimulation
- newly diagnosed
- ejection fraction
- chronic kidney disease
- palliative care
- peritoneal dialysis
- human health
- plasmodium falciparum
- prognostic factors
- risk assessment
- trypanosoma cruzi
- patient reported outcomes
- combination therapy
- patient reported
- replacement therapy